GSK plc GSK
NYSE GSK
$47.83 -0.75 (-1.54%)
At close: Nov 19, 2026 · 4:00 PM EST

Gsk (GSK) Restructuring Costs (2009 - 2017)

Updated

Gsk's Restructuring Costs came in at -$205.79 million for the quarter ended Dec 31, 2017, compared with $1.21 billion a year earlier.

Analysis

Gsk (GSK) Restructuring Costs (2009 - 2017) Analysis & Trends

Over the trailing twelve months to Dec 31, 2017, Gsk reported Restructuring Costs of $1.53 billion, down 23.6% year-over-year; for the year ended Dec 31, 2009, it was -$704.93 million.

  • The figure for the quarter ended Dec 31, 2017 represents the lowest quarterly Restructuring Costs since the quarter ended Sep 30, 2009.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 PetVivo Holdings 3,096.39 Bn 3,096.39 Bn 196,075.00
2 Eli Lilly 1,202.70 Bn 1,176.32 Bn 20.46 Bn
3 Johnson & Johnson 649.77 Bn 569.63 Bn 17.30 Bn
4 AbbVie 507.00 Bn 475.00 Bn 13.12 Bn
5 Merck 329.70 Bn 292.64 Bn 13.19 Bn
6 Novartis Ag 291.91 Bn 265.14 Bn -
7 Amgen 236.26 Bn 187.91 Bn 7.58 Bn
8 Gilead Sciences 207.15 Bn 182.26 Bn 6.73 Bn
9 Gsk 193.54 Bn 176.38 Bn -
10 Pfizer 156.44 Bn 103.79 Bn 12.56 Bn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2017 -205.79 Mn
Dec 31, 2016 1.21 Bn
Sep 30, 2016 198.50 Mn
Jun 30, 2016 336.07 Mn
Mar 31, 2016 269.46 Mn
Dec 31, 2015 2.87 Bn
Dec 31, 2009 248.29 Mn
Sep 30, 2009 -249.40 Mn
API Access

Gsk Restructuring Costs API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=restructuring-costs&ticker=GSK&period=max&api_key=YOUR_API_KEY